Nareg H Roubinian1,2,3, Jeanne E Hendrickson4, Darrell J Triulzi5, Jerome L Gottschall6, Michael Michalkiewicz7, Dhuly Chowdhury8, Daryl J Kor9, Mark R Looney3,10, Michael A Matthay3, Steven H Kleinman11, Donald Brambilla8, Edward L Murphy1,3. 1. Blood Systems Research Institute, San Francisco, CA. 2. Kaiser Permanente Division of Research and Medical Center, Oakland, CA. 3. Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA. 4. Department of Laboratory Medicine, Yale University, New Haven, CT. 5. Department of Pathology, Institute for Transfusion Medicine, Pittsburgh, PA. 6. Department of Pathology, BloodCenter of Wisconsin, Milwaukee, WI. 7. Aurora Research Institute, Milwaukee, WI. 8. RTI International, Rockville, MD. 9. Department of Anesthesia, Mayo Clinic, Rochester, MN. 10. Department of Medicine, University of California, San Francisco, San Francisco, California. 11. Department of Pathology and Laboratory Medicine, University of British Columbia, Victoria, BC, Canada.
Abstract
OBJECTIVES: Transfusion-associated circulatory overload is characterized by hydrostatic pulmonary edema following blood transfusion. Restrictive transfusion practice may affect the occurrence and severity of transfusion-associated circulatory overload in critically ill patients. We sought to examine contemporary risk factors and outcomes for transfusion-associated circulatory overload. DESIGN: Case-control study. SETTING: Four tertiary care hospitals. PATIENTS: We prospectively enrolled 200 patients with transfusion-associated circulatory overload identified by active surveillance and 405 controls matched by transfusion intensity. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Among 20,845 transfused patients who received 128,263 blood components from May 2015 until July 2016, transfusion-associated circulatory overload incidence was one case per 100 transfused patients. In addition to cardiovascular comorbidities, multivariable analysis identified the following independent predictors of transfusion-associated circulatory overload: acute kidney injury, emergency surgery, pretransfusion diuretic use, and plasma transfusion-the latter especially in females. Compared with matched controls, transfusion-associated circulatory overload cases were more likely to require mechanical ventilation (71% vs 49%; p < 0.001), experienced longer intensive care and hospital lengths of stay following transfusion, and had higher mortality (21% vs 11%; p = 0.02) even after adjustment for other potentially confounding variables. CONCLUSIONS: Despite restrictive transfusion practice, transfusion-associated circulatory overload remains a frequent complication of transfusion and is an independent risk factor for in-hospital morbidity and mortality. In addition to cardiovascular and renal risk factors, plasma transfusion was associated with transfusion-associated circulatory overload after controlling for other covariates. Additional research is needed to examine the benefit of reduced erythrocyte or plasma exposure in patients at high risk for transfusion-associated circulatory overload.
OBJECTIVES: Transfusion-associated circulatory overload is characterized by hydrostatic pulmonary edema following blood transfusion. Restrictive transfusion practice may affect the occurrence and severity of transfusion-associated circulatory overload in critically illpatients. We sought to examine contemporary risk factors and outcomes for transfusion-associated circulatory overload. DESIGN: Case-control study. SETTING: Four tertiary care hospitals. PATIENTS: We prospectively enrolled 200 patients with transfusion-associated circulatory overload identified by active surveillance and 405 controls matched by transfusion intensity. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Among 20,845 transfused patients who received 128,263 blood components from May 2015 until July 2016, transfusion-associated circulatory overload incidence was one case per 100 transfused patients. In addition to cardiovascular comorbidities, multivariable analysis identified the following independent predictors of transfusion-associated circulatory overload: acute kidney injury, emergency surgery, pretransfusion diuretic use, and plasma transfusion-the latter especially in females. Compared with matched controls, transfusion-associated circulatory overload cases were more likely to require mechanical ventilation (71% vs 49%; p < 0.001), experienced longer intensive care and hospital lengths of stay following transfusion, and had higher mortality (21% vs 11%; p = 0.02) even after adjustment for other potentially confounding variables. CONCLUSIONS: Despite restrictive transfusion practice, transfusion-associated circulatory overload remains a frequent complication of transfusion and is an independent risk factor for in-hospital morbidity and mortality. In addition to cardiovascular and renal risk factors, plasma transfusion was associated with transfusion-associated circulatory overload after controlling for other covariates. Additional research is needed to examine the benefit of reduced erythrocyte or plasma exposure in patients at high risk for transfusion-associated circulatory overload.
Authors: Ryan A Collins; Mary K Wisniewski; Jonathan H Waters; Darrell J Triulzi; Mark H Yazer Journal: Am J Clin Pathol Date: 2015-03 Impact factor: 2.493
Authors: Nareg H Roubinian; Gabriel J Escobar; Vincent Liu; Bix E Swain; Marla N Gardner; Patricia Kipnis; Darrell J Triulzi; Jerome L Gottschall; Yan Wu; Jeffrey L Carson; Steven H Kleinman; Edward L Murphy Journal: Transfusion Date: 2014-08-18 Impact factor: 3.157
Authors: Pearl Toy; Peter Bacchetti; Barbara Grimes; Ognjen Gajic; Edward L Murphy; Jeffrey L Winters; Michael A Gropper; Rolf D Hubmayr; Michael A Matthay; Gregory Wilson; Monique Koenigsberg; Deanna C Lee; Nora V Hirschler; Clifford A Lowell; Randy M Schuller; Manish J Gandhi; Philip J Norris; David C Mair; Rosa Sanchez Rosen; Mark R Looney Journal: Transfusion Date: 2014-12-08 Impact factor: 3.157
Authors: Edward L Murphy; Nicholas Kwaan; Mark R Looney; Ognjen Gajic; Rolf D Hubmayr; Michael A Gropper; Monique Koenigsberg; Greg Wilson; Michael Matthay; Peter Bacchetti; Pearl Toy Journal: Am J Med Date: 2013-01-26 Impact factor: 4.965
Authors: Nareg H Roubinian; Colleen Plimier; Jennifer P Woo; Catherine Lee; Roberta Bruhn; Vincent X Liu; Gabriel J Escobar; Steven H Kleinman; Darrell J Triulzi; Edward L Murphy; Michael P Busch Journal: Blood Date: 2019-07-26 Impact factor: 22.113
Authors: Marisol Maldonado; Colleen E Villamin; Leah E Murphy; Amitava Dasgupta; Roland L Bassett; Mayrin Correa Medina; Tonita S Bates; Fernando Martinez; Adriana M Knopfelmacher Couchonal; Kimberly Klein; James M Kelley Journal: Lab Med Date: 2022-07-04
Authors: Robert B Klanderman; Joachim J Bosboom; Adrie A W Maas; Joris J T H Roelofs; Dirk de Korte; Robin van Bruggen; Jaap D van Buul; Coert J Zuurbier; Denise P Veelo; Markus W Hollmann; Margreeth B Vroom; Nicole P Juffermans; Bart F Geerts; Alexander P J Vlaar Journal: Transfusion Date: 2019-11-07 Impact factor: 3.157
Authors: Jacob Holmqvist; Anne Brynolf; Jingcheng Zhao; Märit Halmin; Jacob Hollenberg; Johan Mårtensson; Max Bell; Linda Block; Gustaf Edgren Journal: Transfusion Date: 2022-05-31 Impact factor: 3.337
Authors: Joachim J Bosboom; Robert B Klanderman; Lotte E Terwindt; Esther B Bulle; Marije Wijnberge; Susanne Eberl; Antoine H Driessen; Toon A Winkelman; Bart F Geerts; Denise P Veelo; Markus W Hollmann; Alexander P J Vlaar Journal: Vox Sang Date: 2022-05-13 Impact factor: 2.996